Role of Inflammasome Activation in the Pathophysiology of Vascular Diseases of the Neurovascular Unit

被引:77
|
作者
Mohamed, Islam N. [1 ,2 ,3 ]
Ishrat, Tauheed [1 ,3 ]
Fagan, Susan C. [1 ,3 ]
El-Remessy, Azza B. [1 ,2 ,3 ]
机构
[1] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA 30912 USA
[2] Georgia Regents Univ, Culver Vis Discovery Inst, Augusta, GA USA
[3] Charlie Norwood VA Med Ctr, Augusta, GA USA
关键词
THIOREDOXIN-INTERACTING PROTEIN; UP-REGULATED PROTEIN-1; TRAUMATIC BRAIN-INJURY; PATTERN-RECOGNITION RECEPTORS; RETINAL MICROVASCULAR SIGNS; INNATE IMMUNE-RESPONSE; FREE FATTY-ACIDS; FACTOR-KAPPA-B; NLRP3; INFLAMMASOME; ALZHEIMERS-DISEASE;
D O I
10.1089/ars.2014.6126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Inflammation is the standard double-edged defense mechanism that aims at protecting the human physiological homeostasis from devastating threats. Both acute and chronic inflammation have been implicated in the occurrence and progression of vascular diseases. Interference with components of the immune system to improve patient outcome after ischemic injury has been uniformly unsuccessful. There is a need for a deeper understanding of the innate immune response to injury in order to modulate, rather than to block inflammation and improve the outcome for vascular diseases. Recent Advances: Nucleotide-binding oligomerization domain-like receptors or NOD-like receptor proteins (NLRPs) can be activated by sterile and microbial inflammation. NLR family plays a major role in activating the inflammasome. Critical Issues: The aim of this work is to review recent findings that provided insights into key inflammatory mechanisms and define the place of the inflammasome, a multi-protein complex involved in instigating inflammation in neurovascular diseases, including retinopathy, neurodegenerative diseases, and stroke. Future Directions: The significant contribution of NLRP-inflammasome activation to vascular disease of the neurovascular unit in the brain and retina suggests that therapeutic strategies focused on specific targeting of inflammasome components could significantly improve the outcomes of these diseases. Antioxid. Redox Signal. 22, 1188-1206.
引用
收藏
页码:1188 / 1206
页数:19
相关论文
共 50 条
  • [31] Neurovascular Unit: A critical role in ischemic stroke
    Wang, Liyun
    Xiong, Xiaoxing
    Zhang, Luyuan
    Shen, Jian
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (01) : 7 - 16
  • [32] The Role of Pericytes in Neurovascular Unit: Emphasis on Stroke
    Oztop-Cakmak, Ozgur
    Solaroglu, Ihsan
    Gursoy-Ozdemir, Yasemin
    CURRENT DRUG TARGETS, 2017, 18 (12) : 1386 - 1391
  • [33] Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases
    Kahlenberg, J. Michelle
    Kang, Insoo
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (03) : 386 - 395
  • [34] The emerging role of the inflammasome in kidney diseases
    Chang, Anthony
    Ko, Kichul
    Clark, Marcus R.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (03): : 204 - 210
  • [35] The role of the inflammasome in fibrotic respiratory diseases
    Rastrick, J.
    Birrell, M.
    MINERVA MEDICA, 2014, 105 (01) : 9 - 23
  • [36] The role of the inflammasome in patients with autoinflammatory diseases
    Hoffman, Hal M.
    Broderick, Lori
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) : 3 - 15
  • [37] The pathogenic role of the inflammasome in neurodegenerative diseases
    Freeman, Leslie C.
    Ting, Jenny P. -Y.
    JOURNAL OF NEUROCHEMISTRY, 2016, 136 : 29 - 38
  • [38] PATHOPHYSIOLOGY AND MORPHOLOGY OF INFLAMMATORY AND DEGENERATIVE VASCULAR DISEASES
    HEGEWALD
    PHARMAZEUTISCHE PRAXIS-BEITRAGE ZUR ZEITSCHRIFT DIE PHARMAZIE, 1972, (09): : 214 - &
  • [39] Dilating Vascular Diseases: Pathophysiology and Clinical Aspects
    Yetkin, Ertan
    Ozturk, Selcuk
    INTERNATIONAL JOURNAL OF VASCULAR MEDICINE, 2018, 2018
  • [40] Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
    Maki, Takakuni
    Hayakawa, Kazuhide
    Pham, Loc-Duyen D.
    Xing, Changhong
    Lo, Eng H.
    Arai, Ken
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (03) : 302 - 315